| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4a08454e0be1eb7ce34cbd44426ff106
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3ad6ca147da26aa29b0959e8ccf29c67
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_45f6200d1b1583a6098a1c170d0e4ca3 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5158
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5156
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2035-124
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-6037
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-20022 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-001114 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
| filingDate |
2010-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9fb9dc000098a413e7a1de6f57e3d079
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5682afa1b7116f34bcef82fdb8fe2eb0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9548aa8fa3db27aff3d228a27928fb52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d5059e2c2c43e5019717265cb7166499 |
| publicationDate |
2011-02-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2011027311-A1 |
| titleOfInvention |
Combination of protein vaccine and mesenchymal stem cells for treating cancer |
| abstract |
A method for inhibiting growth and/or metastasis of a tumor in a mammal is disclosed. The method comprises administering to a mammal in need thereof an effective amount of stem cells comprising a transgene encoding at least one oncogenic protein, wherein the stem cells are immortal and show no signs of neoplastic transformation, and administering to the mammal a vaccine composition comprising an effective amount of at least one immunogenic protein capable of eliciting at least one antibody specific against the at least one oncogenic protein, and thereby inhibiting growth and/or metastasis of a tumor in the mammal. A therapeutic kit for inhibiting growth and/or metastasis of a tumor in a mammal is also disclosed. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3446708-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11353269-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115381857-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2018111695-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2013370932-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11598594-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014100857-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10357538-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113272390-A |
| priorityDate |
2009-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |